General MedicationsINJECTIONStandard

BLEOMYCIN SULFATE

Standard Dose

EQ 30 UNITS BASE/VIAL

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview BLEOMYCIN SULFATE is listed in Drugs@FDA under application 205030 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BLEOMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 30 UNITS BASE/VIAL Sponsor MEITHEAL Submission history Latest submission status date: 2018-04-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview BLEOMYCIN SULFATE is listed in Drugs@FDA under application 205030 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BLEOMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 30 UNITS BASE/VIAL Sponsor MEITHEAL Submission history Latest submission status date: 2018-04-20 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.